Literature DB >> 1596907

Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11.

T Ichikawa1, Y Ichikawa, J Dong, A L Hawkins, C A Griffin, W B Isaacs, M Oshimura, J C Barrett, J T Isaacs.   

Abstract

Previous studies using somatic cell hybridization of highly metastatic and nonmetastatic rat prostatic cancer cells demonstrated that the resultant hybrids were nonmetastatic if all of the parental chromosomes were retained. Somatic hybrid segregants which underwent nonrandom chromosomal losses reexpressed high metastatic ability. These results demonstrated that there are gene(s) the expression of which can suppress metastatic ability of prostatic cancer cells. To identify the location of homologous gene(s) in the human, specific human chromosomes were introduced into highly metastatic rat prostatic cancer cells using the microcell-mediated chromosome transfer. Introduction of human chromosome 11 into highly metastatic rat prostate cancer cells results in suppression of metastatic ability without suppression of the in vivo growth rate or tumorigenicity of the hybrid cells. Spontaneous deletion of portions of human chromosome 11 in some of the clones delineated the minimal portion of human chromosome 11 capable of suppressing prostatic cancer metastases as the region between 11p11.2-13 but not including the Wilms' tumor-1 locus.

Entities:  

Mesh:

Year:  1992        PMID: 1596907

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

Review 1.  Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

Authors:  J T Isaacs
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Dr. Coffey's visionary contributions to urological research in China and Japan.

Authors:  Jun Shimazaki; Leland Wk Chung; Haiyen E Zhau; Tomohiko Ichikawa
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

Review 3.  Molecular and cellular markers for metastatic prostate cancer.

Authors:  C W Rinker-Schaeffer; W B Isaacs; J T Isaacs
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

4.  Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.

Authors:  J Geradts; R Maynard; M J Birrer; D Hendricks; S L Abbondanzo; K M Fong; J C Barrett; D P Lombardi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

5.  MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.

Authors:  Russell Z Szmulewitz; Robert Clark; Tamara Lotan; Kristen Otto; Jennifer Taylor Veneris; Kay Macleod; Carrie Rinker-Schaeffer
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

Review 6.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

7.  Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.

Authors:  R Shipman; P Schraml; M Colombi; G Raefle; C U Ludwig
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

8.  Fine structure analysis of the WT1 gene in sporadic Wilms tumors.

Authors:  R Varanasi; N Bardeesy; M Ghahremani; M J Petruzzi; N Nowak; M A Adam; P Grundy; T B Shows; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 9.  Metastasis suppressor genes.

Authors:  Jinchun Yan; Qin Yang; Qihong Huang
Journal:  Histol Histopathol       Date:  2013-03       Impact factor: 2.303

10.  Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.

Authors:  K V Honn; A Aref; Y Q Chen; M L Cher; J D Crissman; J D Forman; X Gao; D Grignon; M Hussain; A T Porter; J E Pontes; I Powell; B Redman; W Sakr; R Severson; D G Tang; D P Wood
Journal:  Pathol Oncol Res       Date:  1996-03       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.